CERS2 (ceramide synthase 2)

2011-07-01  

Identity

HGNC
LOCATION
1q21.3
LOCUSID
ALIAS
L3,LASS2,SP260,TMSG1
FUSION GENES

Other Information

Locus ID:

NCBI: 29956
MIM: 606920
HGNC: 14076
Ensembl: ENSG00000143418

Variants:

dbSNP: 29956
ClinVar: 29956
TCGA: ENSG00000143418
COSMIC: CERS2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000143418ENST00000271688Q96G23
ENSG00000143418ENST00000361419Q5SZE4
ENSG00000143418ENST00000368949Q5SZE1
ENSG00000143418ENST00000368954Q96G23
ENSG00000143418ENST00000421609Q5SZE3
ENSG00000143418ENST00000457392Q5SZE2
ENSG00000143418ENST00000558062H0YKH6
ENSG00000143418ENST00000560793H0YLQ6
ENSG00000143418ENST00000561294H0YNU7

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Sphingolipid metabolismKEGGko00600
Sphingolipid metabolismKEGGhsa00600
Metabolic pathwaysKEGGhsa01100
Ceramide biosynthesisKEGGM00094
Sphingosine biosynthesisKEGGM00099
Ceramide biosynthesisKEGGhsa_M00094
Sphingosine biosynthesisKEGGhsa_M00099
Sphingolipid signaling pathwayKEGGhsa04071
Sphingolipid signaling pathwayKEGGko04071
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Sphingolipid metabolismREACTOMER-HSA-428157
Sphingolipid de novo biosynthesisREACTOMER-HSA-1660661

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
381914482024LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells.0
381914482024LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells.0
369460342023[LASS2/TMSG1 overexpression inhibits proliferation and promotes apoptosis of human lung cancer A549 cells possibly by upregulating ceramide and p38 MAPK to activate a signaling cascade].0
369460342023[LASS2/TMSG1 overexpression inhibits proliferation and promotes apoptosis of human lung cancer A549 cells possibly by upregulating ceramide and p38 MAPK to activate a signaling cascade].0
349150262022Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer.4
357349662022Hsa-miR-221-3p promotes proliferation and migration in HER2-positive breast cancer cells by targeting LASS2 and MBD2.0
363002492022LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway.1
349150262022Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer.4
357349662022Hsa-miR-221-3p promotes proliferation and migration in HER2-positive breast cancer cells by targeting LASS2 and MBD2.0
363002492022LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspase‑dependent pathway.1
334233352021Ceramide synthase 2-C(24:1) -ceramide axis limits the metastatic potential of ovarian cancer cells.9
335155462021Ceramide synthase 2 deletion decreases the infectivity of HIV-1.11
335686342021Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype.11
337055512021Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study.5
343834042021MicroRNA-20a Targeting LASS2 Promotes the Proliferation, Invasiveness and Migration of Bladder Cancer.2

Citation

Dessen P

CERS2 (ceramide synthase 2)

Atlas Genet Cytogenet Oncol Haematol. 2011-07-01

Online version: http://atlasgeneticsoncology.org/gene/52300/cers2